Do not trust in low serum level: protein S100B – a case report

Authors

  • Ellen Tackner Medical University of Graz, Department of Orthopedics and Trauma Surgery. Auenbruggerplatz 5, 8036 Graz, AUSTRIA
  • Gloria Hohenberger Medical University of Graz, Department of Orthopedics and Trauma Surgery. Auenbruggerplatz 5, 8036 Graz, AUSTRIA
  • Franz Joseph Seibert Medical University of Graz, Department of Orthopedics and Trauma Surgery. Auenbruggerplatz 5, 8036 Graz, AUSTRIA
  • Uldis Berzins Medical University of Graz, Department of Orthopedics and Trauma Surgery. Auenbruggerplatz 5, 8036 Graz, AUSTRIA
  • Angelika Schwartz AUVA Trauma Hospital Graz, Göstinger Straße 24, 8036 Graz, AUSTRIA
  • Renate Krassnig Medical University of Graz, Department of Orthopedics and Trauma Surgery. Auenbruggerplatz 5, 8036 Graz, AUSTRIA

DOI:

https://doi.org/10.5281/zenodo.5904052

Keywords:

Protein S100B, Traumatic brain injury, Subdural hematoma, Subarachnoid hemorrhage

Abstract

The introduction of the calcium-binding peptide protein S100B into traumatic brain injury diagnostics proves to be a potential screening alternative for patients who need a computed tomography (CT) scan. The current literature estimates that this biomarker could reduce unnecessary cranial CTs and the included hazards of ionization by about one third. Authors report the case of a young patient with an S100B serum level directly at the reference point after mild traumatic brain injury, who turned out to have a subdural hematoma, subarachnoid hemorrhage and a temporal skull fracture.

References

Cervellin G, Benatti M, Carbucicchio A, Mattei L, Cerasti D, Aloe R, Lippi G. Serum levels of protein S100B predict intracranial lesions in mild head injury. Clinical biochemistry. 2012; 45 (6): 408-411. doi: 10.1016/j.clinbiochem.2012.01.006.

Thelin EP, Nelson DW, Bellander BM. A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury. Acta neurochirurgica. 2017; 159 (2): 209-225. doi: 10.1007/s00701-016-3046-3.

Welch RD, Ayaz SI, Lewis LM, Unden J, Chen JY, Mika VH, Saville B, Tyndall JA, Nash M, Buki A, Barzo P, Hack D, Tortella FC, Schmid K, Hayes RL, Vossough A, Sweriduk ST, Bazarian JJ. Ability of Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and S100B To Differentiate Normal and Abnormal Head Computed Tomography Findings in Patients with Suspected Mild or Moderate Traumatic Brain Injury. Journal of neurotrauma. 2016; 33 (2): 203-214. doi: 10.1089/neu.2015.4149.

Kleindienst A, Ross Bullock M. A critical analysis of the role of the neurotrophic protein S100B in acute brain injury. Journal of neurotrauma. 2006; 23 (8): 1185-1200. doi: 10.1089/neu.2006.23.1185.

Rostami E, Gyorgy A, Davidsson J, Walker J, Wingo D, Angeria M, Bellander B-M, Agoston D, Risling M. Time-Dependent Changes in Serum Level of Protein Biomarkers after Focal Traumatic Brain Injury. International Journal of Neurorehabilitation. 2015; 2 (168). doi: 10.4172/2376-0281.1000168.

Shakeri M, Mahdkhah A, Panahi F. S100B Protein as a Post-traumatic Biomarker for Prediction of Brain Death in Association With Patient Outcomes. Archives of trauma research. 2013; 2 (2): 76-80. doi: 10.5812/atr.8549.

Yardan T, Erenler AK, Baydin A, Aydin K, Cokluk C. Usefulness of S100B protein in neurological disorders. JPMA The Journal of the Pakistan Medical Association. 2011; 61 (3): 276-281.

Heidari K, Asadollahi S, Jamshidian M, Abrishamchi SN, Nouroozi M. Prediction of neuropsychological outcome after mild traumatic brain injury using clinical parameters, serum S100B protein and findings on computed tomography. Brain injury. 2015; 29 (1): 33-40. doi: 10.3109/02699052.2014.948068.

Undén J, Romner B. Can low serum levels of S100B predict normal CT findings after minor head injury in adults?: an evidence-based review and meta-analysis. The Journal of head trauma rehabilitation. 2010; 25 (4): 228-240. doi: 10.1097/HTR.0b013e3181e57e22.

Asadollahi S, Heidari K, Taghizadeh M, Seidabadi AM, Jamshidian M, Vafaee A, Manoochehri M, Shojaee AH, Hatamabadi HR. Reducing head computed tomography after mild traumatic brain injury: Screening value of clinical findings and S100B protein levels. Brain injury. 2016; 30 (2): 172-178. doi: 10.3109/02699052.2015.1091504.

Downloads

Published

2017-12-30

How to Cite

Tackner, E., Hohenberger, G., Seibert, F. J., Berzins, U., Schwartz, A., & Krassnig, R. (2017). Do not trust in low serum level: protein S100B – a case report. BioMedicine and Surgery, 1(4), 176–178. https://doi.org/10.5281/zenodo.5904052

Issue

Vol. 1 No. 4 (2017)

Section

Case report

License

Copyright (c) 2022 Ellen Tackner, Gloria Hohenberger, Franz Joseph Seibert, Uldis Berzins, Angelika Schwartz, Renate Krassnig

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Articles in BioMedicine and Surgery are published under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International license. Full text of Attribution-NonCommercial-NoDerivatives 4.0 International license can be viewed at https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode.